Metformin in the treatment of patients with non-alcoholic steatohepatitis


Uygun A., Kadayifci A., IŞIK A. T., Ozgurtas T., Deveci S., Tuzun A., ...Daha Fazla

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, cilt.19, sa.5, ss.537-544, 2004 (SCI-Expanded) identifier identifier identifier

Özet

Background: Increased insulin resistance is the major pathogenic mechanism in the development of non-alcoholic steatohepatitis.